Valuation: Rani Therapeutics Holdings, Inc.

Market Cap 70.87M 62.02M 57.15M 52.98M 101M 6.73B 102M 685M 267M 3.32B 266M 260M 11.47B P/E 2026 *
-3.67x
P/E 2027 * -3.22x
Enterprise Value 70.87M 62.02M 57.15M 52.98M 101M 6.73B 102M 685M 267M 3.32B 266M 260M 11.47B EV / Sales 2026 *
17.2x
EV / Sales 2027 * 14.4x
Free-Float
78.3%
Yield 2026 *
-
Yield 2027 * -
1 day-10.55%
1 week-6.72%
Current month-6.72%
1 month-14.49%
3 months-13.25%
6 months-48.97%
Current year-47.46%
1 week 0.7
Extreme 0.6999
0.83
1 month 0.7
Extreme 0.6999
0.85
Current year 0.68
Extreme 0.68
1.54
1 year 0.39
Extreme 0.387
3.87
3 years 0.39
Extreme 0.387
8.75
5 years 0.39
Extreme 0.387
36.27
10 years 0.39
Extreme 0.387
36.27
Manager TitleAgeSince
Chief Executive Officer 45 01/06/2021
Director of Finance/CFO 46 29/06/2026
Chief Tech/Sci/R&D Officer 42 01/01/2022
Director TitleAgeSince
Director/Board Member 69 06/04/2021
Director/Board Member 80 01/09/2018
Chairman 69 01/06/2021
Date Insider Type Main position Quantity % Market Cap.
06-03Free

Executive/Senior Manager

805,500 0.8077%
06-03Free

Chief Technology Officer

805,500 0.8077%
06-03Free

Founder

3,800,000 3.8106%
Change 5-day change 1-year change 3-year change Capi.($)
-10.55%-6.72%+32.26%-84.02% 70.87M
-0.89%+1.44%+73.45%+128.95% 57.72B
-3.80%-6.24%+67.04%+86.36% 52.65B
+1.17%+5.83%+16.39%+468.18% 24.46B
+0.38%+1.33%-14.32%-11.76% 23.84B
-3.05%+3.06%+42.36%-5.66% 19.28B
-0.29%+5.38%+44.61%-26.43% 17.8B
+3.46%+17.72%+206.66%+364.07% 17.29B
-6.73%+9.90%+36.04% - 15.28B
+2.79%+4.91%+29.26%+195.60% 14.35B
Average -1.75%+3.97%+53.37%+123.92% 24.27B
Weighted average by Cap. -1.16%+2.58%+57.61%+139.25%

Financials

2026 *2027 *
Net sales 4.13M 3.61M 3.33M 3.09M 5.86M 392M 5.95M 39.92M 15.52M 193M 15.5M 15.16M 668M 4.92M 4.31M 3.97M 3.68M 6.99M 467M 7.1M 47.63M 18.52M 231M 18.49M 18.09M 797M
Net income -33.21M -29.07M -26.79M -24.83M -47.13M -3.15B -47.89M -321M -125M -1.56B -125M -122M -5.38B -39.93M -34.94M -32.2M -29.85M -56.66M -3.79B -57.57M -386M -150M -1.87B -150M -147M -6.46B
Net Debt - -
Logo Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
Employees
70
Date Price Change Volume
07/07/26 $0.7093 -10.55% 1,579,084
06/07/26 $0.7930 +2.81% 950,800
02/07/26 $0.7713 +0.38% 504,534
01/07/26 $0.7684 +1.05% 473,116
30/06/26 $0.7604 -0.56% 213,003
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.7093USD
Average target price
7.500USD
Spread / Average Target
+957.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RANI Stock